TW · Healthcare

BORA PHARMACEUTICALS LTD (6472)

Drug Manufacturers - Specialty & Generic

BORA PHARMACEUTICALS LTD (6472) is listed on TW in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 6472

P/E ratio

18.00

BORA PHARMACEUTICALS LTD (6472) — FAQ

What is 6472's P/E ratio?

The price-to-earnings (P/E) ratio for BORA PHARMACEUTICALS LTD (6472) is 18.00 (data as of 2026-05-23).

Does BORA PHARMACEUTICALS LTD pay a dividend?

Dividend yield is not available in the current snapshot for BORA PHARMACEUTICALS LTD (6472). Check the MyAverix Finance app for the latest dividend data.

What sector is BORA PHARMACEUTICALS LTD in?

BORA PHARMACEUTICALS LTD (6472) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 6472 listed on?

6472 is listed on TW.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)